Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics Statistics

Total Valuation

NMRA has a market cap or net worth of $382.63 million. The enterprise value is $231.20 million.

Market Cap	382.63M
Enterprise Value	231.20M

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

NMRA has 167.09 million shares outstanding. The number of shares has increased by 2.49% in one year.

Current Share Class	167.09M
Shares Outstanding	167.09M
Shares Change (YoY)	+2.49%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	4.91%
Owned by Institutions (%)	31.08%
Float	89.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.81
P/TBV Ratio	2.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.85, with a Debt / Equity ratio of 0.15.

Current Ratio	6.85
Quick Ratio	6.64
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-203.38

Financial Efficiency

Return on equity (ROE) is -104.35% and return on invested capital (ROIC) is -63.22%.

Return on Equity (ROE)	-104.35%
Return on Assets (ROA)	-56.71%
Return on Invested Capital (ROIC)	-63.22%
Return on Capital Employed (ROCE)	-158.30%
Revenue Per Employee	n/a
Profits Per Employee	-$2.15M
Employee Count	110
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NMRA has paid $130,000 in taxes.

Income Tax	130,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.32% in the last 52 weeks. The beta is 3.03, so NMRA's price volatility has been higher than the market average.

Beta (5Y)	3.03
52-Week Price Change	-76.32%
50-Day Moving Average	2.21
200-Day Moving Average	1.46
Relative Strength Index (RSI)	45.45
Average Volume (20 Days)	1,775,284

Short Selling Information

The latest short interest is 6.10 million, so 3.65% of the outstanding shares have been sold short.

Short Interest	6.10M
Short Previous Month	6.54M
Short % of Shares Out	3.65%
Short % of Float	6.80%
Short Ratio (days to cover)	2.53

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-240.60M
Pretax Income	-236.17M
Net Income	-236.30M
EBITDA	-240.24M
EBIT	-240.60M
Earnings Per Share (EPS)	-$1.46

Balance Sheet

The company has $171.53 million in cash and $20.09 million in debt, giving a net cash position of $151.44 million or $0.91 per share.

Cash & Cash Equivalents	171.53M
Total Debt	20.09M
Net Cash	151.44M
Net Cash Per Share	$0.91
Equity (Book Value)	132.16M
Book Value Per Share	0.82
Working Capital	151.24M

Cash Flow

In the last 12 months, operating cash flow was -$208.83 million and capital expenditures $759,000, giving a free cash flow of -$208.07 million.

Operating Cash Flow	-208.83M
Capital Expenditures	759,000
Free Cash Flow	-208.07M
FCF Per Share	-$1.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.49%
Shareholder Yield	-2.49%
Earnings Yield	-61.76%
FCF Yield	-54.38%

Analyst Forecast

The average price target for NMRA is $7.57, which is 230.57% higher than the current price. The consensus rating is "Buy".

Price Target	$7.57
Price Target Difference	230.57%
Analyst Consensus	Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-35.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1